These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9601521)

  • 1. The bis-azo compound FP-21399 inhibits HIV-1 replication by preventing viral entry.
    Zhang JL; Choe H; Dezube BJ; Farzan M; Sharma PL; Zhou XC; Chen LB; Ono M; Gillies S; Wu Y; Sodroski JG; Crumpacker CS
    Virology; 1998 May; 244(2):530-41. PubMed ID: 9601521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FP-21399 blocks HIV envelope protein-mediated membrane fusion and concentrates in lymph nodes.
    Ono M; Wada Y; Wu Y; Nemori R; Jinbo Y; Wang H; Lo KM; Yamaguchi N; Brunkhorst B; Otomo H; Wesolowski J; Way JC; Itoh I; Gillies S; Chen LB
    Nat Biotechnol; 1997 Apr; 15(4):343-8. PubMed ID: 9094135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic factors control efficiencies of cell entry, efficacies of entry inhibitors, and mechanisms of adaptation of human immunodeficiency virus.
    Platt EJ; Durnin JP; Kabat D
    J Virol; 2005 Apr; 79(7):4347-56. PubMed ID: 15767435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5.
    Dragic T; Trkola A; Thompson DA; Cormier EG; Kajumo FA; Maxwell E; Lin SW; Ying W; Smith SO; Sakmar TP; Moore JP
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5639-44. PubMed ID: 10779565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress in targeting HIV-1 entry.
    Ryser HJ; Flückiger R
    Drug Discov Today; 2005 Aug; 10(16):1085-94. PubMed ID: 16182193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with impaired gp120 shedding and gp41 exposure.
    Fischer PB; Karlsson GB; Dwek RA; Platt FM
    J Virol; 1996 Oct; 70(10):7153-60. PubMed ID: 8794362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion.
    Veazey RS; Klasse PJ; Schader SM; Hu Q; Ketas TJ; Lu M; Marx PA; Dufour J; Colonno RJ; Shattock RJ; Springer MS; Moore JP
    Nature; 2005 Nov; 438(7064):99-102. PubMed ID: 16258536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-1-antitrypsin interacts with gp41 to block HIV-1 entry into CD4+ T lymphocytes.
    Zhou X; Liu Z; Zhang J; Adelsberger JW; Yang J; Burton GF
    BMC Microbiol; 2016 Jul; 16(1):172. PubMed ID: 27473095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140.
    Trkola A; Ketas TJ; Nagashima KA; Zhao L; Cilliers T; Morris L; Moore JP; Maddon PJ; Olson WC
    J Virol; 2001 Jan; 75(2):579-88. PubMed ID: 11134270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics.
    Reeves JD; Gallo SA; Ahmad N; Miamidian JL; Harvey PE; Sharron M; Pohlmann S; Sfakianos JN; Derdeyn CA; Blumenthal R; Hunter E; Doms RW
    Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16249-54. PubMed ID: 12444251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Envelope glycoprotein determinants of increased entry in a pathogenic simian-human immunodeficiency virus (SHIV-HXBc2P 3.2) passaged in monkeys.
    Si Z; Gorry P; Babcock G; Owens CM; Cayabyab M; Phan N; Sodroski J
    AIDS Res Hum Retroviruses; 2004 Feb; 20(2):163-73. PubMed ID: 15018704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 entry and its inhibition.
    Pierson TC; Doms RW
    Curr Top Microbiol Immunol; 2003; 281():1-27. PubMed ID: 12932074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FP 21399.
    Drugs R D; 1999 Nov; 2(5):343-4. PubMed ID: 10728476
    [No Abstract]   [Full Text] [Related]  

  • 14. Agonist-induced internalization of CC chemokine receptor 5 as a mechanism to inhibit HIV replication.
    Ferain T; Hoveyda H; Ooms F; Schols D; Bernard J; Fraser G
    J Pharmacol Exp Ther; 2011 Jun; 337(3):655-62. PubMed ID: 21389095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immunodeficiency virus type 1 entry and chemokine receptors: a new therapeutic target.
    Cammack N
    Antivir Chem Chemother; 1999 Mar; 10(2):53-62. PubMed ID: 10335399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nef stimulates human immunodeficiency virus type 1 replication in primary T cells by enhancing virion-associated gp120 levels: coreceptor-dependent requirement for Nef in viral replication.
    Lundquist CA; Zhou J; Aiken C
    J Virol; 2004 Jun; 78(12):6287-96. PubMed ID: 15163722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly potent inhibition of human immunodeficiency virus type 1 replication by TAK-220, an orally bioavailable small-molecule CCR5 antagonist.
    Takashima K; Miyake H; Kanzaki N; Tagawa Y; Wang X; Sugihara Y; Iizawa Y; Baba M
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3474-82. PubMed ID: 16048963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline susceptibility of primary human immunodeficiency virus type 1 to entry inhibitors.
    Labrosse B; Labernardière JL; Dam E; Trouplin V; Skrabal K; Clavel F; Mammano F
    J Virol; 2003 Jan; 77(2):1610-3. PubMed ID: 12502877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of small-molecule CCR5 antagonists on human immunodeficiency virus type 1 envelope-mediated membrane fusion and viral replication.
    Takashima K; Miyake H; Furuta RA; Fujisawa JI; Iizawa Y; Kanzaki N; Shiraishi M; Okonogi K; Baba M
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3538-43. PubMed ID: 11709336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane-fusing capacity of the human immunodeficiency virus envelope proteins determines the efficiency of CD+ T-cell depletion in macaques infected by a simian-human immunodeficiency virus.
    Etemad-Moghadam B; Rhone D; Steenbeke T; Sun Y; Manola J; Gelman R; Fanton JW; Racz P; Tenner-Racz K; Axthelm MK; Letvin NL; Sodroski J
    J Virol; 2001 Jun; 75(12):5646-55. PubMed ID: 11356972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.